2 Stocks Swim Green and 2 Stocks Sink Red

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

In the Red:

Nielsen Hldg NV (NYSE:NLSN): On slides which will be presented at the William Blair Growth Stock Conference, the company says that FY headwinds include Buy, Western Europe, global multinational client investments, and foreign currency impact. Tailwinds include Walmart (NYSE:WMT) data live, bettering markets growth, and OCR adoption. Nielsen Holdings continues to see FY12 EPS $1.76-$1.82, consensus $1.80. Shares of Nielsen Hldg NV are trading .94% lower today.

Investing Insights: SPIN ZONE: Facebook Starts ORWELLIAN Campaign for Investors>>

A123 Systems, Inc. (NASDAQ:AONE): Although A123 Systems and First Solar (NASDAQ:FSLR) saw huge gains yesterday, A123 Systems have fallen 17.7% and First Solar has fallen 4.4%. Part of A123′s decline is a result of Wunderlich’s comments, and First Solar’s fall is credited to JPMorgan’s note which argues that yesterday’s rally did not possess “much, if any, structural long buying.” Shares of A123 Systems, Inc. are trading 17.72% lower today.

In the Green:

FactSet Research Systems Inc. (NYSE:FDS): Though analysts were expecting a revenue of $202.9M, FactSet Research Systems saw a 10.2% rise in revenue to $202.3M from the year-earlier quarter. The company reported an adjusted net income of $1.15 per share, meaning that the company beat the $1.04 per share mean estimate. Shares of FactSet Research Systems Inc. are trading 0.28% higher today.

Biostar Pharmaceuticals Inc (NASDAQ:BSPM): Biostar Pharmaceuticals has signed a Letter of Intent with the Fourth Military Medical University in order to conduct Phases I to III clinical trial for the Viacom Pine II Cream drug. The letter was sent to China’s military authorities to seek approval. Viacom is prescribed specifically for China’s military needs and will also be used to treat skin problems including bacterial and fungal infections, and dermatitis and eczema. Before the military approves the drug for production, trials must be conducted for three years. Shares of Biostar Pharmaceuticals Inc are trading 48.6% higher today.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business